Cargando…

Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints

BACKGROUND: To support public health policy, information on the burden of disease is essential. In recent years, the Disability-Adjusted Life Year (DALY) has emerged as the most important summary measure of public health. DALYs quantify the number of healthy life years lost due to morbidity and mort...

Descripción completa

Detalles Bibliográficos
Autores principales: Devleesschauwer, Brecht, Maertens de Noordhout, Charline, Smit, G Suzanne A, Duchateau, Luc, Dorny, Pierre, Stein, Claudia, Van Oyen, Herman, Speybroeck, Niko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246467/
https://www.ncbi.nlm.nih.gov/pubmed/25416547
http://dx.doi.org/10.1186/1471-2458-14-1196
_version_ 1782346520367988736
author Devleesschauwer, Brecht
Maertens de Noordhout, Charline
Smit, G Suzanne A
Duchateau, Luc
Dorny, Pierre
Stein, Claudia
Van Oyen, Herman
Speybroeck, Niko
author_facet Devleesschauwer, Brecht
Maertens de Noordhout, Charline
Smit, G Suzanne A
Duchateau, Luc
Dorny, Pierre
Stein, Claudia
Van Oyen, Herman
Speybroeck, Niko
author_sort Devleesschauwer, Brecht
collection PubMed
description BACKGROUND: To support public health policy, information on the burden of disease is essential. In recent years, the Disability-Adjusted Life Year (DALY) has emerged as the most important summary measure of public health. DALYs quantify the number of healthy life years lost due to morbidity and mortality, and thereby facilitate the comparison of the relative impact of diseases and risk factors and the monitoring of public health over time. DISCUSSION: Evidence on the disease burden in Belgium, expressed as DALYs, is available from international and national efforts. Non-communicable diseases and injuries dominate the overall disease burden, while dietary risks, tobacco smoking, and high body-mass index are the major risk factors for ill health. Notwithstanding these efforts, if DALYs were to be used for guiding health policy, a more systematic approach is required. By integrating DALYs in the current data generating systems, comparable estimates, rooted in recent local data, can be produced. This might however be hampered by several restrictions, such as limited harmonization, timeliness, inclusiveness and accessibility of current databases. SUMMARY: Routine quantification of disease burden in terms of DALYs would provide a significant added value to evidence-based public health policy in Belgium, although some hurdles need to be cleared.
format Online
Article
Text
id pubmed-4246467
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42464672014-11-29 Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints Devleesschauwer, Brecht Maertens de Noordhout, Charline Smit, G Suzanne A Duchateau, Luc Dorny, Pierre Stein, Claudia Van Oyen, Herman Speybroeck, Niko BMC Public Health Debate BACKGROUND: To support public health policy, information on the burden of disease is essential. In recent years, the Disability-Adjusted Life Year (DALY) has emerged as the most important summary measure of public health. DALYs quantify the number of healthy life years lost due to morbidity and mortality, and thereby facilitate the comparison of the relative impact of diseases and risk factors and the monitoring of public health over time. DISCUSSION: Evidence on the disease burden in Belgium, expressed as DALYs, is available from international and national efforts. Non-communicable diseases and injuries dominate the overall disease burden, while dietary risks, tobacco smoking, and high body-mass index are the major risk factors for ill health. Notwithstanding these efforts, if DALYs were to be used for guiding health policy, a more systematic approach is required. By integrating DALYs in the current data generating systems, comparable estimates, rooted in recent local data, can be produced. This might however be hampered by several restrictions, such as limited harmonization, timeliness, inclusiveness and accessibility of current databases. SUMMARY: Routine quantification of disease burden in terms of DALYs would provide a significant added value to evidence-based public health policy in Belgium, although some hurdles need to be cleared. BioMed Central 2014-11-21 /pmc/articles/PMC4246467/ /pubmed/25416547 http://dx.doi.org/10.1186/1471-2458-14-1196 Text en © Devleesschauwer et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Devleesschauwer, Brecht
Maertens de Noordhout, Charline
Smit, G Suzanne A
Duchateau, Luc
Dorny, Pierre
Stein, Claudia
Van Oyen, Herman
Speybroeck, Niko
Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
title Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
title_full Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
title_fullStr Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
title_full_unstemmed Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
title_short Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
title_sort quantifying burden of disease to support public health policy in belgium: opportunities and constraints
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246467/
https://www.ncbi.nlm.nih.gov/pubmed/25416547
http://dx.doi.org/10.1186/1471-2458-14-1196
work_keys_str_mv AT devleesschauwerbrecht quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT maertensdenoordhoutcharline quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT smitgsuzannea quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT duchateauluc quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT dornypierre quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT steinclaudia quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT vanoyenherman quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints
AT speybroeckniko quantifyingburdenofdiseasetosupportpublichealthpolicyinbelgiumopportunitiesandconstraints